Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors
Clinical trial NCT07245901 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07245901
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-05
- Primary completion
- 2028-12-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.